enVVeno Medical Corporati... (NVNO)
enVVeno Medical Statistics
Share Statistics
enVVeno Medical has 17.54M shares outstanding. The number of shares has increased by 31.68% in one year.
| Shares Outstanding | 17.54M |
| Shares Change (YoY) | 31.68% |
| Shares Change (QoQ) | 31.55% |
| Owned by Institutions (%) | 26.53% |
| Shares Floating | 17.37M |
| Failed to Deliver (FTD) Shares | 522 |
| FTD / Avg. Volume | 0.51% |
Short Selling Information
The latest short interest is 442.4K, so 2.52% of the outstanding shares have been sold short.
| Short Interest | 442.4K |
| Short % of Shares Out | 2.52% |
| Short % of Float | 2.55% |
| Short Ratio (days to cover) | 2.07 |
Valuation Ratios
The PE ratio is -2.37 and the forward PE ratio is -2.67. enVVeno Medical's PEG ratio is 0.07.
| PE Ratio | -2.37 |
| Forward PE | -2.67 |
| PS Ratio | 0 |
| Forward PS | 1 |
| PB Ratio | 1.23 |
| P/FCF Ratio | -3.07 |
| PEG Ratio | 0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for enVVeno Medical Corporation.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.88, with a Debt / Equity ratio of 0.03.
| Current Ratio | 20.88 |
| Quick Ratio | 20.88 |
| Debt / Equity | 0.03 |
| Total Debt / Capitalization | 2.46 |
| Cash Flow / Debt | -15.83 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.52% and return on capital (ROIC) is -55.12%.
| Return on Equity (ROE) | -0.52% |
| Return on Assets (ROA) | -0.49% |
| Return on Capital (ROIC) | -55.12% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-589,702.7 |
| Employee Count | 37 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -49.45% in the last 52 weeks. The beta is 1.38, so enVVeno Medical's price volatility has been higher than the market average.
| Beta | 1.38 |
| 52-Week Price Change | -49.45% |
| 50-Day Moving Average | 3.18 |
| 200-Day Moving Average | 3.96 |
| Relative Strength Index (RSI) | 37.92 |
| Average Volume (20 Days) | 102.08K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -23.83M |
| Net Income | -21.82M |
| EBITDA | -23.83M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.27 |
Balance Sheet
The company has 1.75M in cash and 1.06M in debt, giving a net cash position of 690K.
| Cash & Cash Equivalents | 1.75M |
| Total Debt | 1.06M |
| Net Cash | 690K |
| Retained Earnings | -151.85M |
| Total Assets | 44.95M |
| Working Capital | 41.64M |
Cash Flow
In the last 12 months, operating cash flow was -16.84M and capital expenditures -37K, giving a free cash flow of -16.88M.
| Operating Cash Flow | -16.84M |
| Capital Expenditures | -37K |
| Free Cash Flow | -16.88M |
| FCF Per Share | -0.98 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NVNO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -46.18% |
| FCF Yield | -35.06% |
Analyst Forecast
Currently there are no analyst rating for NVNO.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 30, 2020. It was a backward split with a ratio of 1:25.
| Last Split Date | Nov 30, 2020 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | 5.3 |
| Piotroski F-Score | 2 |